Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1998;31:986-994

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bray, P.
Right arrow Articles by Bobik, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bray, P.
Right arrow Articles by Bobik, A.

(Hypertension. 1998;31:986-994.)
© 1998 American Heart Association, Inc.


Scientific Contributions

Transforming Growth Factor-ß and Receptor Tyrosine Kinase–Activating Growth Factors Negatively Regulate Collagen Genes in Smooth Muscle of Hypertensive Rats

Paula Bray; Alex Agrotis; ; Alex Bobik

From Baker Medical Research Institute, Alfred Hospital, Prahran, Victoria, Australia.

Correspondence to Dr A. Bobik, Baker Medical Research Institute, Commercial Road, PO Box 348, Prahran, Victoria 3181 Australia. E-mail Alex.Bobik{at}alice.baker.edu.au

Abstract—Previous studies have suggested that differences in vascular smooth muscle cell (VSMC) proliferative responses between spontaneously hypertensive rats (SHR) and normotensive Wistar-Kyoto (WKY) rats can be attributed to transforming growth factor-ß (TGF-ß) actions. Because vascular collagen content is reported to be lower in SHR than in WKY rats, in this study we investigated in cell culture whether the differences in collagen content might also be attributed to differential actions of TGF-ß on VSMCs from the two strains. Exposure of VSMCs from WKY to the TGF-ß isoforms -ß1, -ß2, or -ß3 induced rapid, transient elevations in mRNAs encoding collagens {alpha}1(I), {alpha}2(I), and {alpha}1(III); maximum increases were apparent by 2 hours and ranged from twofold [collagen {alpha}1(III)] to ninefold [collagen {alpha}1(I)]. Thereafter they returned to near basal levels. When VSMCs from SHR were exposed to these TGF-ß isoforms, only reductions in collagen mRNA levels were observed, persisting for 24 hours. Basic fibroblast growth factor and epidermal growth factor, factors known to stimulate production of the TGF-ß1 isoform in VSMCs, also induced a pattern of gene responses similar to those induced by the TGF-ß isoforms in VSMCs from SHR and WKY rats. The simultaneous presence of TGF-ß did not affect the time course or magnitude of the changes in collagens {alpha}1(I), {alpha}2(I), or {alpha}1(III) mRNA levels in SHR or WKY VSMCs. Examination of the induction of c-myc mRNA and immunoreactive oncoprotein content indicated that c-myc is a likely contributor to the downregulation of the collagen gene activity in both SHR and WKY VSMCs despite the differential regulation of its mRNA by TGF-ß1 in the two VSMC lines. Together these data suggest that in VSMCs from SHR, a number of gene responses to TGF-ß, in addition to cell proliferation, appear to be abnormal compared with WKY rats, and the lower than normal collagen levels observed in the vasculature of SHR may be in part due to abnormalities in TGF-ß responsiveness.


Key Words: : • transforming growth factor-ß • receptor protein–tyrosine kinase • collagen • genes, c-myc • muscle, smooth, vascular • rats, inbred SHR




This article has been cited by other articles:


Home page
HypertensionHome page
H. D. Intengan and E. L. Schiffrin
Vascular Remodeling in Hypertension: Roles of Apoptosis, Inflammation, and Fibrosis
Hypertension, September 1, 2001; 38(3): 581 - 587.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
R. E. Gilbert, J. R. Rumble, Z. Cao, A. J. Cox, P. van Eeden, T. J. Allen, D. J. Kelly, and M. E. Cooper
Endothelin Receptor Antagonism Ameliorates Mast Cell Infiltration, Vascular Hypertrophy, and Epidermal Growth Factor Expression in Experimental Diabetes
Circ. Res., February 4, 2000; 86(2): 158 - 165.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. D. Smith, S. R. Bryant, L. L. Couper, C. P. H. Vary, P. J. Gotwals, V. E. Koteliansky, and V. Lindner
Soluble Transforming Growth Factor-ß Type II Receptor Inhibits Negative Remodeling, Fibroblast Transdifferentiation, and Intimal Lesion Formation But Not Endothelial Growth
Circ. Res., May 28, 1999; 84(10): 1212 - 1222.
[Abstract] [Full Text] [PDF]